Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Qamar Khan, MD
University of Kansas Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- City of Hope National Medical Center
Duarte, California, United States
- Cancer Research Collaboration
Santa Ana, California, United States
- University of Miami Sylvester Comprehensive Cancer Center
Deerfield Beach, Florida, United States
- University of Kansas Cancer Center - West
Kansas City, Kansas, United States
- University of Kansas Cancer Center - Overland Park
Overland Park, Kansas, United States
- University of Kansas Cancer Center - Westwood
Westwood, Kansas, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Kansas Cancer Center - North
Kansas City, Missouri, United States
- University of Kansas Cancer Center - South
Kansas City, Missouri, United States
- University of Kansas Cancer Center - Lee'S Summit
Lee's Summit, Missouri, United States
- Columbia University Medical Center
New York, New York, United States
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2016
- Primary completion
- 27 Aug 2018
- Completion
- 31 Dec 2026
- Last update posted
- 11 Mar 2026
- Registered enrollment
- 121
- Registry id
- NCT02712723
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.